Can an over-the-counter vitamin-like substance slow the progression of Parkinson's disease?
Rush University Medical Center is participating in a large-scale, multi-center clinical trial in the U.S. and Canada to determine whether a vitamin-like substance, in high doses, can slow the progression of Parkinson's disease, a neurodegenerative disorder that affects about one million people in the United States. view more (2009-09-22)
Statins don't lower risk of pneumonia in elderly
Taking popular cholesterol-lowering statin drugs, such as Lipitor® (atorvastatin), does not lower the risk of pneumonia. view more (2009-06-17)
Naturally fluorescent molecules may serve as cancer biomarker
Excess amounts of a naturally fluorescent molecule found in all living cells could serve as a natural biomarker for cancer, according to bioengineers. view more (2009-04-03)
Discovery of Tuberculosis Bacterium Enzyme Paves Way for New TB Drugs
A team of University of Maryland scientists has paved the way for the development of new drug therapies to combat active and asymptomatic (latent) tuberculosis infections by characterizing the unique structure and mechanism of an enzyme in M. tuberculosis, the bacterium that causes the disease. Assistant Professor of Chemistry and Biochemistry... view more... (2009-03-30)
Enzyme cocktail converts cellulosic materials, water into hydrogen fuel
Tomorrow's fuel-cell vehicles may be powered by enzymes that consume cellulose from woodchips or grass and exhale hydrogen. view more (2009-02-12)
Queen's chemist sheds light on health benefits of garlic
Researchers have widely believed that the organic compound, allicin - which gives garlic its aroma and flavour - acts as the world's most powerful antioxidant. But until now it hasn't been clear how allicin works, or how it stacks up compared to more common antioxidants such as Vitamin E and coenzyme Q10, which stop the damaging effects of... view more... (2009-02-02)
First comprehensive paper on statins' adverse effects released
A paper co-authored by Beatrice Golomb, MD, PhD, associate professor of medicine at the University of California, San Diego School of Medicine and director of UC San Diego's Statin Study group cites nearly 900 studies on the adverse effects of HMG-CoA reductase inhibitors (statins), a class of drugs widely used to treat high cholesterol. view more (2009-01-27)
UC Santa Barbara chemist goes nano with CoQ10
If Bruce Lipshutz has his way, you may soon be buying bottles of water brimming with the life-sustaining coenzyme CoQ10 at your local Costco. view more (2008-07-25)
Statin treatment may curb Alzheimer's brain changes
People who take statin drugs may be less likely to develop the brain changes that signal Alzheimer's disease, according to a study published in the August 28, 2007, issue of Neurology(r), the medical journal of the American Academy of Neurology. view more (2007-08-28)
Monell researchers find metabolic defect in liver that can lead to obesity
Researchers at the Monell Chemical Senses Center have identified a genetically-transmitted metabolic defect that can lead to obesity in some individuals. view more (2007-07-25)
Energy supplement under study for Parkinson's disease
Whether a supplement used by athletes to boost energy levels and build muscle can slow progression of Parkinson's disease is the focus of a North American study. view more (2007-03-22)
Protein sensor for fatty acid buildup in mitochondria
Just as homes have smoke detectors, cells have an enzyme that responds to a buildup of fatty acids by triggering the production of a key molecule in the biochemical pathway that breaks down these fatty acids, according to investigators at St. Jude Children's Research Hospital. view more (2007-02-15)
Metabolic disorder not well-suited for inclusion in newborn screening programs
A metabolic disorder that can lead to developmental delay and other problems is more common than previously assumed, but does not meet major criteria for inclusion in newborn screening programs at this time. view more (2006-08-23)
Chewing up a key regulator of fat synthesis keeps mice lean despite a high-fat diet
Scientists at the Salk Institute for Biological Studies have identified a novel pathway that regulates the body's ability to store or burn fat, a discovery that suggests new ways to reduce obesity, diabetes and other fat-related human diseases. view more (2006-06-23)
Novel protein complex enables survival in hostile environment
Biswarup Mukhopadhyay and Eric Johnson from the Virginia Bioinformatics Institute at Virginia Tech have discovered a novel enzyme that represents an ancient detoxification system and provides a clue to the development of early metabolism on earth. view more (2005-11-17)
Researchers call on cancer charities to administer 'seal of approval' scheme for complementary and alternative cancer websites
Complementary medicine researchers are urging major cancer organisations and other impartial interest groups to investigate websites offering complementary and alternative medical advice on cancer, and to create and administer a 'seal of approval' for their safety and reliability. The call comes after their analysis of 32 English-language websites... view more... (2004-04-12)
Swiss National Science Foundation project demonstrates inherited ability to adapt to life at high altitudes
Extra enzymes protect Tibetans against muscle damage at high altitudes Tibetans' muscles are better protected against hypoxia at high altitudes than those of lowland dwellers since Tibetans produce more of the enzymes that neutralize free radicals in muscle tissue. This ability to adapt to life at over 3,500 metres above sea level is at least... view more... (2004-02-19)
|
|
